Source: Eur Respir J 2014; 44: 1369-1372
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Woodfield Georgia, Passey-Heaton Benjamin, Chakrabarti Anob, Pozniak Anton, Loebinger Michael R.. An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy. Eur Respir J 2014; 44: 1369-1372

Member's Comments

No comment yet.

Related content which might interest you: Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 False-negative interferon gamma release assay results in active tuberculosis: a TBNET study Source: Eur Respir J 2015; 45: 279-283 Year: 2015 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 The incidence of tuberculosis in patients taking anti TNF alpha therapy Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Adherence to national guidelines for interferon gamma release assay in diagnosis of mycobacterium tuberculosis Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Potential value of an ELISPOT interferon gamma release assay as a diagnostic tool in Q fever infection Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1512-1513 Year: 2015 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1510-1512 Year: 2015 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Comparative performance of interferon gamma release assays in detection of latent tuberculosis infection among health-care professionals Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Comparison of LTBI screening strategies before TNF inhibitor treatment in inflammatory arthritis Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010